VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,998,812 | -80.7% | 84,019 | -79.3% | 0.02% | -82.8% |
| Q1 2023 | $10,348,407 | -20.3% | 406,777 | -8.5% | 0.14% | -25.3% |
| Q4 2022 | $12,978,938 | +87.9% | 444,332 | +31.9% | 0.19% | +84.8% |
| Q3 2022 | $6,908,000 | +804.2% | 336,790 | +409.7% | 0.10% | +775.0% |
| Q2 2022 | $764,000 | -17.4% | 66,073 | +32.1% | 0.01% | +9.1% |
| Q1 2022 | $925,000 | -6.5% | 50,000 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $989,000 | +20.2% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $823,000 | +47.8% | 50,000 | +50.0% | 0.01% | +25.0% |
| Q1 2021 | $557,000 | – | 33,333 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |